View in EDS

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.

Saved in:
Bibliographic Details
Title: Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.
Authors: Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France. Electronic address: birgit.geoerger@gustaveroussy.fr., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands; Princess Máxima Center, Utrecht, Netherlands., Marshall LV; Paediatric and Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Michon J; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France., Bourdeaut F; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Corradini N; Haematology and Oncology Paediatric Institut, Léon Bérard Centre, Lyon, France., Rossato G; F Hoffmann-La Roche, Basel, Switzerland., Farid-Kapadia M; F Hoffmann-La Roche, Mississauga, Canada., Shemesh CS; Genentech, San Francisco, CA, USA., Hutchinson KE; Genentech, San Francisco, CA, USA., Donaldson F; F Hoffmann-La Roche, Welwyn, UK., Liao M; Genentech, San Francisco, CA, USA., Caron H; F Hoffmann-La Roche, Basel, Switzerland., Trippett T; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Source: The Lancet. Oncology [Lancet Oncol] 2020 Jan; Vol. 21 (1), pp. 134-144. Date of Electronic Publication: 2019 Nov 25.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31780255
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Geoerger+B%22">Geoerger B</searchLink>; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France. Electronic address: birgit.geoerger@gustaveroussy.fr.<br /><searchLink fieldCode="AU" term="%22Zwaan+CM%22">Zwaan CM</searchLink>; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands; Princess Máxima Center, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Marshall+LV%22">Marshall LV</searchLink>; Paediatric and Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Michon+J%22">Michon J</searchLink>; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bourdeaut+F%22">Bourdeaut F</searchLink>; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Casanova+M%22">Casanova M</searchLink>; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Corradini+N%22">Corradini N</searchLink>; Haematology and Oncology Paediatric Institut, Léon Bérard Centre, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Rossato+G%22">Rossato G</searchLink>; F Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Farid-Kapadia+M%22">Farid-Kapadia M</searchLink>; F Hoffmann-La Roche, Mississauga, Canada.<br /><searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hutchinson+KE%22">Hutchinson KE</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Donaldson+F%22">Donaldson F</searchLink>; F Hoffmann-La Roche, Welwyn, UK.<br /><searchLink fieldCode="AU" term="%22Liao+M%22">Liao M</searchLink>; Genentech, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Caron+H%22">Caron H</searchLink>; F Hoffmann-La Roche, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Trippett+T%22">Trippett T</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2020 Jan; Vol. 21 (1), pp. 134-144. <i>Date of Electronic Publication: </i>2019 Nov 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31780255
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(19)30693-X
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 134
    Titles:
      – TitleFull: Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): a multicentre phase 1-2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Geoerger B
      – PersonEntity:
          Name:
            NameFull: Zwaan CM
      – PersonEntity:
          Name:
            NameFull: Marshall LV
      – PersonEntity:
          Name:
            NameFull: Michon J
      – PersonEntity:
          Name:
            NameFull: Bourdeaut F
      – PersonEntity:
          Name:
            NameFull: Casanova M
      – PersonEntity:
          Name:
            NameFull: Corradini N
      – PersonEntity:
          Name:
            NameFull: Rossato G
      – PersonEntity:
          Name:
            NameFull: Farid-Kapadia M
      – PersonEntity:
          Name:
            NameFull: Shemesh CS
      – PersonEntity:
          Name:
            NameFull: Hutchinson KE
      – PersonEntity:
          Name:
            NameFull: Donaldson F
      – PersonEntity:
          Name:
            NameFull: Liao M
      – PersonEntity:
          Name:
            NameFull: Caron H
      – PersonEntity:
          Name:
            NameFull: Trippett T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020 Jan
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1474-5488
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Lancet. Oncology
              Type: main
ResultId 1